share_log

Earnings Miss: Herbalife Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

Earnings Miss: Herbalife Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

收益不佳:康宝莱有限公司每股收益下降了16%,分析师正在修改预测
Simply Wall St ·  02/17 07:28

Shareholders in Herbalife Ltd. (NYSE:HLF) had a terrible week, as shares crashed 33% to US$8.07 in the week since its latest full-year results. Revenues were in line with forecasts, at US$5.1b, although statutory earnings per share came in 16% below what the analysts expected, at US$1.42 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

康宝莱有限公司(纽约证券交易所代码:HLF)的股东经历了糟糕的一周,自公布最新的全年业绩以来,本周股价暴跌33%,至8.07美元。收入与预期一致,为51亿美元,尽管每股法定收益比分析师预期的1.42美元低16%。对于投资者来说,盈利是一个重要时刻,因为他们可以追踪公司的业绩,查看分析师对明年的预测,看看对公司的情绪是否发生了变化。根据这些结果,我们收集了最新的法定预测,以了解分析师是否改变了盈利模式。

earnings-and-revenue-growth
NYSE:HLF Earnings and Revenue Growth February 17th 2024
纽约证券交易所:HLF收益和收入增长 2024年2月17日

Following last week's earnings report, Herbalife's five analysts are forecasting 2024 revenues to be US$5.09b, approximately in line with the last 12 months. Per-share earnings are expected to soar 43% to US$2.05. In the lead-up to this report, the analysts had been modelling revenues of US$5.14b and earnings per share (EPS) of US$3.07 in 2024. The analysts seem to have become more bearish following the latest results. While there were no changes to revenue forecasts, there was a large cut to EPS estimates.

继上周的财报之后,康宝莱的五位分析师预测2024年的收入为50.9亿美元,与过去12个月大致持平。每股收益预计将飙升43%,至2.05美元。在本报告发布之前,分析师一直在模拟2024年的收入为51.4亿美元,每股收益(EPS)为3.07美元。最新业绩公布后,分析师似乎变得更加看跌。尽管收入预测没有变化,但每股收益的预期已大幅下调。

It might be a surprise to learn that the consensus price target fell 21% to US$13.60, with the analysts clearly linking lower forecast earnings to the performance of the stock price. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Herbalife, with the most bullish analyst valuing it at US$19.00 and the most bearish at US$10.00 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

得知共识目标股价下跌21%至13.60美元,这可能令人惊讶,分析师明确将较低的预测收益与股价表现联系起来。但是,这并不是我们可以从这些数据中得出的唯一结论,因为一些投资者在评估分析师目标股价时也喜欢考虑估计值的差异。对康宝莱的看法有所不同,最看涨的分析师将其估值为19.00美元,最看跌的为每股10.00美元。注意到分析师目标股价的巨大差距了吗?对我们来说,这意味着基础业务存在相当广泛的可能情景。

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's pretty clear that there is an expectation that Herbalife's revenue growth will slow down substantially, with revenues to the end of 2024 expected to display 0.5% growth on an annualised basis. This is compared to a historical growth rate of 1.3% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 7.1% annually. Factoring in the forecast slowdown in growth, it seems obvious that Herbalife is also expected to grow slower than other industry participants.

我们可以从大局的角度看待这些估计值的另一种方式,例如预测如何与过去的表现相提并论,以及预测相对于业内其他公司是否或多或少看涨。很明显,预计康宝莱的收入增长将大幅放缓,预计到2024年底的收入按年计算将增长0.5%。相比之下,过去五年的历史增长率为1.3%。相比之下,该行业的其他公司(根据分析师的预测),后者的总体收入预计每年将增长7.1%。考虑到预计的增长放缓,很明显,康宝莱的增长速度预计也将低于其他行业参与者。

The Bottom Line

底线

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Herbalife's revenue is expected to perform worse than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

要了解的最重要的一点是,分析师下调了每股收益的预期,这表明公布这些业绩后,市场情绪明显下降。幸运的是,分析师还重申了他们的收入预期,表明收入符合预期。尽管我们的数据确实表明,康宝莱的收入预计将比整个行业的表现差。此外,分析师还下调了目标股价,这表明最新消息加剧了人们对业务内在价值的悲观情绪。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Herbalife analysts - going out to 2025, and you can see them free on our platform here.

考虑到这一点,我们仍然认为该业务的长期发展轨迹对于投资者来说更为重要。多位康宝莱分析师估计,到2025年,你可以在我们的平台上免费查看。

Even so, be aware that Herbalife is showing 4 warning signs in our investment analysis , and 2 of those are concerning...

即便如此,请注意,康宝莱在我们的投资分析中显示出4个警告信号,其中2个与之有关...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发